Presentation is loading. Please wait.

Presentation is loading. Please wait.

Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose by Wolfgang Römer, Axel-R. Hanauske, Sibylle.

Published byÈve Juneau Modified over 6 years ago

Similar presentations

Presentation on theme: "Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose by Wolfgang Römer, Axel-R. Hanauske, Sibylle."— Presentation transcript:

1 Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose by Wolfgang Römer, Axel-R. Hanauske, Sibylle Ziegler, Ralf Thödtmann, Wolfgang Weber, Christoph Fuchs, Wolfgang Enne, Michael Herz, Christoph Nerl, Manfred Garbrecht, and Markus Schwaiger Blood Volume 91(12): June 15, 1998 ©1998 by American Society of Hematology

2 (A) Bulky high-grade NHL in the left parahilar region with prominent FDG uptake.
(A) Bulky high-grade NHL in the left parahilar region with prominent FDG uptake. The patient (no. 5) showed CR over a follow-up period of 15 months. (B) Extensive mediastinal tumor mass of a high-grade NHL with an additional focal tumor lesion in the right lower lobe. The patient (no. 6) exhibited partial remission at day 42, but relapsed during the third course of chemotherapy. Myocardial FDG uptake at day 7 and day 42 does not reflect tumor involvement. Wolfgang Römer et al. Blood 1998;91: ©1998 by American Society of Hematology

3 Wolfgang Römer et al. Blood 1998;91:4464-4471
©1998 by American Society of Hematology

4 Wolfgang Römer et al. Blood 1998;91:4464-4471
©1998 by American Society of Hematology

Download ppt "Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose by Wolfgang Römer, Axel-R. Hanauske, Sibylle."

Similar presentations

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.
Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A

Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A
Volume 13, Issue 6, Pages (June 2013)

Volume 13, Issue 6, Pages (June 2013)
A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma.

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma.
Staging of diffuse large B-cell lymphoma (DLBCL)

Staging of diffuse large B-cell lymphoma (DLBCL)
How I treat extramedullary myeloma

How I treat extramedullary myeloma
Fowler NH et al. Proc ASCO 2010;Abstract 8036.

Fowler NH et al. Proc ASCO 2010;Abstract 8036.
Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.
by James O. Armitage, and Dan L. Longo

by James O. Armitage, and Dan L. Longo
Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.

Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.
Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S

Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11):3909-3918 June 1, 1997 ©1997.

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
by Thomas S. Uldrick, and Richard F. Little

by Thomas S. Uldrick, and Richard F. Little
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.

Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,

In Stem Cell Transplantation by Limiting the Morbidity of Graft-versus-Host Disease Tolerance to Myeloablative Conditioning is Improved  Nicolas Novitzky,
Chemokine and Chemokine Receptor Gene Variants and Risk of Non-Hodgkin’s Lymphoma in Human Immunodeficiency Virus-1–Infected Individuals by Charles S.

Chemokine and Chemokine Receptor Gene Variants and Risk of Non-Hodgkin’s Lymphoma in Human Immunodeficiency Virus-1–Infected Individuals by Charles S.
Nonmyeloablative conditioning for relapsed follicular lymphoma

Nonmyeloablative conditioning for relapsed follicular lymphoma
Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster.

Short-pulse B–non-Hodgkin lymphoma–type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster.

Similar presentations

Ads by Google